In the month of June, the Society of Critical Care Medicine (SCCM) will feature a webcast on a critical care topic pertinent to quality patient care:
Use of Corticosteroids in Septic Shock
Tuesday, June 24, 2014
1:00 p.m. Central TimeRegister online today
Septic shock is a serious condition often seen in the intensive care unit. Treatment is complicated and options vary. In this webcast from the Society of Critical Care Medicine’s Controversies in Critical Care
series, the rationale for use or avoidance of corticosteroids in critically ill patients with septic shock will be discussed. Djilalli Annane, MD, and Greet Van den Berghe, MD, PhD, will highlight the controversies surrounding the use of low-dose corticosteroids and the association with clinical outcomes. The registration fee for this 60-minute webcast is $30 for SCCM members ($40 for nonmembers). For institutions seeking unlimited participation, a $200 group rate is available. Participants will receive 1 hour of continuing education credit. Learning Objectives
•List the rationales for the use of low-dose steroids in septic shock
•Explain the controversies surrounding steroid use and clinical outcomes
•Describe the context in which steroids should be used (e.g., dose, duration, severe sepsis versus septic shock)
•Outline the end points for use of steroids (e.g., mortality versus shock reversal)
•Categorize the adverse effects expected for steroid use in the critically ill
•Review the 2012 Surviving Sepsis Campaign
guidelines regarding recommendations for steroid use
If you have any questions regarding this webcast, please contact SCCM Customer Service
at +1 847 827-6888.
The Controversies in Critical Care webcast series is a joint project of the SCCM Scientific Review Committee and the American College of Critical Care Medicine’s Ethics Committee. This series is intended to provide insight into topics in critical care medicine for which no clear consensus or unequivocal evidence is available to guide practice decisions.